Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors

Behavioural Brain Research

Volumn 284, Issue , 2015, Pages 37-41

  Emery, Michael A ^a   Bates, M L Shawn ^a   Wellman, Paul J ^a   Eitan, Shoshana ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Abuse; Addiction; Analgesics; Opioid; Pain management

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HYDROCODONE; MORPHINE; OXYCODONE; QUINPIROLE; DOPAMINE RECEPTOR STIMULATING AGENT; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; REWARD; RISK; TREATMENT DURATION; AGONISTS; AKATHISIA; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; HEAT; METABOLISM; PAIN; PAIN MEASUREMENT;

AKATHISIA, DRUG-INDUCED; ANALGESICS, OPIOID; ANIMALS; DOPAMINE AGONISTS; HOT TEMPERATURE; HYDROCODONE; MALE; MICE, INBRED C57BL; MORPHINE; OXYCODONE; PAIN; PAIN MEASUREMENT; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 84923062446     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.01.023     Document Type: Article

References (30)

1. Lee J.M., DeLeon-Jones F., Fields J.Z., Ritzmann R.F. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine. Alcohol Drug Res 1987, 7:1-10.
2. Reddy P.L., Veeranna, Thorat S.N., Bhargava H.N. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats. Brain Res 1993, 607:293-300.
3. Piepponen T.P., Katajamäki J., Kivastik T., Zharkovsky A., Ahtee L. Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole. Pharmacol Biochem Behav 1996, 54:787-792.
4. Druhan J.P., Walters C.L., Aston-Jones G. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther 2000, 294:531-538.
5. Hofford R.S., Wellman P.J., Eitan S. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice. J Psychopharm 2012, 26:1355-1365.
6. Barwatt J.W., Hofford R.S., Emery M.A., Bates M.L., Wellman P.J., Eitan S. Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice. Drug Alcohol Depend 2013, 132:420-426.
7. Elmer G.I., Pieper J.O., Rubinstein M., Low M.J., Grandy D.K., Wise R.A. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 2002, 22:RC224.
8. Dockstader C.L., Rubinstein M., Grandy D.K., Low M.J., van der Kooy D. The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice. Eur J Neurosci 2001, 13:995-1001.
9. De Vries T.J., Schoffelmeer A.N., Binnekade R., Vanderschuren L.J. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 1999, 143:254-260.
10. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388:586-589.
11. Smith J.W., Fetsko L.A., Xu R., Wang Y. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience 2002, 113:755-765.
12. Blum K., Noble E.P., Sheridan P.J., Finley O., Montgomery A., Ritchie T., et al. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991, 8:409-416.
13. Nemoda Z., Szekely A., Sasvari-Szekely M. Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev 2011.
14. Esposito-Smythers C., Spirito A., Rizzo C., McGeary J.E., Knopik V.S. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav 2009, 93:306-312.
15. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther 2011, 17:118-132.
16. Gershon A.A., Vishne T., Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 2007, 61:145-153.
17. Svestka J. Treatment of bipolar depression. Neuro Endocrinol Lett 2005, 26(Suppl. 1):27-47.
18. Hofford R.S., Wellman P.J., Eitan S. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice. J Psychopharmacol 2012, 26:1355-1365.
19. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 2000, 24:137-141.
20. Druhan J.P., Walters C.L., Aston-Jones G. Behavioral activation induced by D2-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther 2000, 294:531-538.
21. Starke K., Gothert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 1989, 69:864-989.
22. Usiello A., Baik J.-H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000, 408:199-203.
23. Mogenson G.J., Wu M. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 1991, 551:216-220.
24. Millan M.J., Seguin L., Gobert A., Cussac D., Brocco M. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology (Berl) 2004, 174:341-357.
25. Marsteller D.A., Gerald C.P.G., Kong R., Cajina M., Craig D.A., Swanson C.J. The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice. Eur J Pharmacol 2009, 602:66-72.
26. Halberda J.P., Middaugh L.D., Gard B.E., Jackson B.P. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse 1997, 26:81-92.
27. Georges F., Stinus L., Bloch B., Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 1999, 11:481-490.
28. Navarro M., Fernández-Ruiz J.J., Rodriguez De Fonseca F., Hernández M.L., Cebeira M., Ramos J.A. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice. Pharmacol Biochem Behav 1992, 43:603-608.
29. Elwan M.A., Soliman M.R. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates. Pharmacology 1995, 51:73-83.
30. Wang X., Liu Y., Lei Y., Zhou D., Fu Y., Che Y., et al. Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal. Neurosci Lett 2008, 433:178-182.